ENSG

The Ensign Group Inc
NASDAQHEALTHCAREMEDICAL CARE FACILITIES

Key Statistics

Market Cap
$9.93B
P/E Ratio
27.86
EPS
$6.10
Beta
0.69
52W High
$217.84
52W Low
$134.59
50-Day MA
$168.58
200-Day MA
$182.81
Dividend Yield
0.15%
Profit Margin
6.89%
Forward P/E
22.27
PEG Ratio
1.48

About The Ensign Group Inc

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$5.27B
Gross Profit (TTM)$866.58M
EBITDA$556.63M
Operating Margin8.99%
Return on Equity16.90%
Return on Assets5.41%
Revenue/Share (TTM)$91.76
Book Value$40.84
Price-to-Book4.16
Price-to-Sales (TTM)1.88
EV/Revenue2.177
EV/EBITDA19.31
Quarterly Earnings Growth (YoY)21.90%
Quarterly Revenue Growth (YoY)18.40%
Shares Outstanding$58.45M
Float$55.85M
% Insiders3.52%
% Institutions94.80%

Historical Volatility

HV 10-Day
33.07%
HV 20-Day
33.21%
HV 30-Day
39.68%
HV 60-Day
33.16%
HV Rank
86.5%

Volatility is currently contracting

Analyst Ratings

Consensus ($220.40 target)
1
Strong Buy
3
Buy
1
Hold

Latest News

The Ensign Group (ENSG) Shares Fall Amid Activist Forensic Reports Challenging Patient Care Claims, Legal Compliance – HBSS

SAN FRANCISCO, July 09, 2026 (GLOBE NEWSWIRE) -- The Ensign Group (NASDAQ: ENSG) investors saw the price of their shares in the skilled nursing facilities (“SNFs”) provider tumble over 8% on June 8 and another 3% on June 11, 2026 after Hunterbrook Media and Muddy Waters Research, respectively, published highly critical reports questioning Ensign's business practices. In total, over $500 million of Ensign's market capitalization has been wiped out since June 7, 2026, the day before the first of the two reports.

GlobeNewsWire7/9/2026Neutral
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages The Ensign Group, Inc. Investors to Inquire About Securities Class Action Investigation - ENSG

New York, New York--(Newsfile Corp. - July 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Ensign securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Newsfile Corp7/9/2026Neutral
THE ENSIGN GROUP, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates The Ensign Group, Inc.'s Directors and Officers for Breach of Fiduciary Duties – ENSG

NEW YORK--(BUSINESS WIRE)---- $ENSG #NASDAQ--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of The Ensign Group, Inc. (NASDAQ: ENSG) failed to manage The Ensign Group in an acceptable manner, breaching their fiduciary duties to Ensign Group, and whether Ensign Group and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On June 11, 2026, Muddy Waters Resear.

Business Wire7/8/2026Neutral
$ENSG Investment Loss: Ensign Investors that Lost Money after Regulatory Issues Disclosed are Notified to Contact BFA Law about its Securities Fraud Investigation

NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into The Ensign Group, Inc. (NASDAQ:ENSG) for potential securities fraud after significant stock drops. If you invested in Ensign, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ensign-class-action-lawsuit.

GlobeNewsWire7/8/2026Neutral
ENSG INVESTIGATION: Investigation Launched into The Ensign Group, Inc. and Attorneys Encourage Investors and Potential Witnesses to Contact Robbins Geller Rudman & Dowd LLP

SAN DIEGO, July 6, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving The Ensign Group, Inc. (NASDAQ: ENSG). If you any have information that could assist in the Ensign investigation or if you are an Ensign investor who suffered a loss and would like to learn more, you may provide your information here: https://www.rgrdlaw.com/cases-the-ensign-group-inc-investigation-ensg.html You can also contact attorneys Ken Dolitsky or Michael Albert of Robbins Geller by calling 800/851-7783 or via e-mail at info@rgrdlaw.com.

PRNewsWire7/6/2026Neutral
$ENSG Fraud Notification: BFA Law is Investigating Ensign for Securities Fraud After Research Reports Spark an 8% Stock Drop – Investors Notified to Contact the Firm

NEW YORK, July 06, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into The Ensign Group, Inc. (NASDAQ:ENSG) for potential securities fraud after significant stock drops. If you invested in Ensign, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ensign-class-action-lawsuit.

GlobeNewsWire7/6/2026Neutral

More HEALTHCARE Stocks

Data last updated: 7/9/2026